Last Updated 30 September 2022.
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: reliefweb.int
Non Replicating Viral Vector
Approved in 93 countries
38 trials in 17 countries
Approval Source: reuters.com
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form